Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 12/20 | 0.49 |
| ▸ | CNR1 | P21554 | 2/20 | 0.44 |
| ▸ | CNR2 | P34972 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.41 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.41 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.41 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.41 |
| ▸ | HRH1 | P35367 | 1/20 | 0.41 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | FNTA | P49354 | 1/20 | 0.40 |
| ▸ | FNTB | P49356 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28850336 | 0.89 | FAAH (0.51) | FAAHCNR1CNR2POLBLMNA | |
| SCHEMBL28850271 | 0.82 | FAAH (0.50) | FAAHCNR1CNR2POLBLMNA | |
| SCHEMBL20898384 | 0.80 | NOS2 (0.51) | FAAHCNR1CNR2POLBLMNA | |
| SCHEMBL20900383 | 0.80 | NOS2 (0.51) | FAAHCNR1CNR2POLBLMNA | |
| SCHEMBL29631806 | 0.80 | NOS2 (0.51) | FAAHCNR1CNR2POLBLMNA | |
| SCHEMBL5154387 | 0.78 | FAAH (0.41) | FAAHCNR1CNR2POLB | |
| SCHEMBL28097062 | 0.78 | POLB (0.46) | FAAHCNR1CNR2POLBLMNA | |
| SCHEMBL8583410 | 0.78 | FAAH (0.53) | FAAHLMNACHRM2ADRA2BSLC6A2 | |
| SCHEMBL7683665 | 0.78 | DRD2 (0.46) | FAAH | |
| SCHEMBL28093862 | 0.77 | GPR119 (0.51) | FAAHCNR1POLBLMNACHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7282589-B2 | Acid addition salt of optically active piperidine compound and process for preparing the same | UBE INDUSTRIES, LTD. (JP) | 2007-10-16 | — | — | US | disclosed |
| US-20040220226-A1 | Acid addition salt of optically active piperidine compound and process for preparing the same | UBE INDUSTRIES, LTD. | 2004-11-04 | — | — | US | disclosed |
| US-6780877-B2 | ANTIHISTAMINIC ACTIVITY, ANTI-ALLERGIC ACTIVITY | UBE INDUSTRIES, LTD. (JP) | 2004-08-24 | — | — | US | disclosed |
| EP-0949260-A1 | ACID-ADDITION SALTS OF OPTICALLY ACTIVE PIPERIDINE COMPOUND AND PROCESS FOR PRODUCING THE SAME | UBE INDUSTRIES, LTD. (JP) | 1999-10-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040220226-A1 | Acid addition salt of optically active piperidine compound and process for preparing the same | DCTPP1, SSRP1, ITPA | FAAH 1684/4885CNR1 1689/4885CNR2 1904/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.